CN111393347A
|
|
Synthetic method of ralotinib intermediate
|
CN111518007A
|
|
Synthesis method of (S) -3-pyrrolidinol hydrochloride
|
CN111333561A
|
|
Synthetic method of ralotinib intermediate (2R) -2- (2, 5-difluorophenyl) pyrrolidine
|
CN111362854A
|
|
Preparation method of ralotinib intermediate
|
CN109678789A
|
|
A method of regulating and controlling pyridine derivate catalytic hydrogenation reaction using oxidation-reduction potential
|
CN109574982A
|
|
A kind of method of solid acid catalysis synthesis Vilantro intermediate
|
CN109574817A
|
|
A method of Vilantro intermediate is synthesized in the mixed solvent
|
CN109678701A
|
|
A kind of preparation method of Vilantro intermediate
|
CN109574861A
|
|
A kind of method for crystallising of three phenylacetate of Vilantro
|
CN109574860A
|
|
A method of preparing Vilantro
|
CN108704082A
|
|
A kind of datura flower carsickness-proof oral solution
|
CN108658797A
|
|
A kind of synthesis of Mirabegron intermediate (R) -2- (4- nitrophenethyls amino) -1- phenylethanol hydrochlorides
|
CN108727212A
|
|
A kind of synthesis of Mirabegron intermediate (R) -2- hydroxy-ns-(4- nitrophenethyls) -2- phenyl-acetamides
|
CN108440379A
|
|
A kind of method of the alkene bisamination synthesis nitrogen-containing hetero cyclics of water phase
|
CN108593793A
|
|
A method of hyoscine is isolated and purified using coordination column chromatography
|
CN108610339A
|
|
The technique of extraction separation hyoscine in a kind of datura flower from low content
|
CN107879962A
|
|
A kind of preparation method of glycopyrronium bromide
|
CN107235972A
|
|
A kind of method that use membrane separation technique extracts hyoscine
|
CN107383001A
|
|
A kind of method that hyoscine in datura flower is extracted by subcritical carbon dioxide abstraction technique
|
CN106083871A
|
|
The method for extraction and purification of hyoscine in a kind of datura flower
|